Tigen, K. Et Al. 2009. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.. The American journal of the medical sciences , vol.337, no.2 , 109-15.

Tigen, K., Karaahmet, T., Cevik, C., Gurel, E., Mutlu, B., & Basaran, Y., (2009). Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.. The American journal of the medical sciences , vol.337, no.2, 109-15.

Tigen, MUSTAFA Et Al. "Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.," The American journal of the medical sciences , vol.337, no.2, 109-15, 2009

Tigen, MUSTAFA K. Et Al. "Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.." The American journal of the medical sciences , vol.337, no.2, pp.109-15, 2009

Tigen, K. Et Al. (2009) . "Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.." The American journal of the medical sciences , vol.337, no.2, pp.109-15.

@article{article, author={MUSTAFA KÜRŞAT TİGEN Et Al. }, title={Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.}, journal={The American journal of the medical sciences}, year=2009, pages={109-15} }